Call Us
+919173178176
Contact Us For Help
Home » Products » Cardiovascular Drugs » Levosimendan Injection

Levosimendan Injection

Levosimendan Injection
Levosimendan Injection
Send Inquiry
Product Code : Levosimendan Injecti
Product Description

Levosimendan Injection has been administered for management of decompensated congestive heart failure. Main chemical of this injection has molecular formula C14H12N6O with molar mass of 280.28 g/mol and elimination half life of about 1 hour. It is a calcium sensitizer which increases cardiac contractility without any rise in Ca++ level. This injection enhances sensitivity of calcium to heart by exerting positive inotropic effects. It is also known to have vasodilatory effects that are achieved due to opening of ATP sensitive potassium channels. Levosimendan Injection shows bioavailability of about 85% with protein binding ability of 97 to 98%. It is mainly metabolized in liver and excreted in urine & feces.

 

 

Product Details:

Minimum Order Quantity 1000 Unit
Dose/Strength (ex. 1 mg or 1ml) 12.5 mg
Packaging Size 5 ml
Packaging Type Vial
Usage Clinical, Hospital
We are leading Exporter and Manufacturer of Levosimendan Lyophilized Injection.
Uses
Levosimendan is used in heart failure
How it works
Levosimendan makes the heart pump blood with more strength and force, which increases the blood circulation throughout the body.
Common side effects
Insomnia (difficulty in sleeping), Decrease in blood pressure, Headache, Hypokalemic (decreased potassium level in blood) alkalosis, Nausea, Increased heart rate, Constipation, Irregular heart rate 

Levosimendan Lyophilized Injection Lyophilized Injection exporter, Levosimendan Lyophilized Injection Lyophilized Injection manufacturer

Levosimendan Lyophilized Injection Lyophilized Injection supplier, Levosimendan Lyophilized Injection Lyophilized Injection manufacturer in India,

Levosimendan Lyophilized Injection Lyophilized Injection exporter in India.


ACTIZA PHARMACEUTICAL PRIVATE LIMITED
X


We are looking forward to foreign inquiries.